Efficacy of the WalkAide and AFOs for CVA


Phase N/A Results

Summary of Purpose

To assess the effectiveness of a new stimulator (WalkAide) for the treatment of foot drop. The comparison will involve physical measurements (e.g. walking speed, physiological cost index, Modified Rivermead Mobility Index, etc.) and questionnaires on the quality of life and acceptance of the technology by stroke survivors.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 April 2013.

1 Sep 2005 19 Sep 2005 1 Nov 2008 1 Nov 2008 1 Apr 2013 18 Apr 2013
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Crossover Assignment


Not available